xanthophylls - CISMeF

Preferred Label : xanthophylls;

MeSH definition : Oxygenated forms of carotenoids. They are usually derived from alpha and beta carotene.;

MeSH synonym : carotenoids, xanthophyll; xanthophyll carotenoids;

Wikipedia automatic translation : Xanthophyll;

Wikipedia link : https://en.wikipedia.org/wiki/Xanthophyll;

Is substance : O;

Détails

Origin ID

D024341;

UMLS CUI

C0949636;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Lutein [SMS substance]
- Lutein [NCIt concept]
- xanthophylls [IUPAC Term]
Record concept(s)
- xanthophylls [MeSH concept]
Related MeSH Supplementary Concept(s)
- 15,15'-didehydroastaxanthin [MeSH Supplementary Concept]
- 2-hydroxymyxol-2'-fucoside [MeSH Supplementary Concept]
- 3-methoxyzeaxanthin [MeSH Supplementary Concept]
- 7,8,7',8'-tetradehydroastaxanthin [MeSH Supplementary Concept]
- 7,8-didehydroastaxanthin [MeSH Supplementary Concept]
- 7-apoastaxanthinal [MeSH Supplementary Concept]
- 9-apoastaxanthinone [MeSH Supplementary Concept]
- CDV-085 [MeSH Supplementary Concept]
- alloxanthin [MeSH Supplementary Concept]
- alpha-doradexanthin [MeSH Supplementary Concept]
- amarouciaxanthin A [MeSH Supplementary Concept]
- amarouciaxanthin B [MeSH Supplementary Concept]
- antheraxanthin [MeSH Supplementary Concept]
- astaxanthin dilysinate tetrahydrochloride [MeSH Supplementary Concept]
- astaxanthin diphosphate [MeSH Supplementary Concept]
- astaxanthin-s-allyl cysteine biconjugate [MeSH Supplementary Concept]
- astaxanthine [MeSH Supplementary Concept]
- astaxantin, calcium, citrus bioflavoid, lycopene, vitamin D3 drug combination [MeSH Supplementary Concept]
- beta-cryptoxanthin laurate [MeSH Supplementary Concept]
- beta-cryptoxanthin myristate [MeSH Supplementary Concept]
- beta-isocryptoxanthin [MeSH Supplementary Concept]
- caloxanthin 3'-beta-D-glucoside [MeSH Supplementary Concept]
- capsanthin [MeSH Supplementary Concept]
- capsanthin-5,6-epoxide [MeSH Supplementary Concept]
- capsorubin [MeSH Supplementary Concept]
- cucumariaxanthin A [MeSH Supplementary Concept]
- cucumariaxanthin B [MeSH Supplementary Concept]
- cucumariaxanthin C [MeSH Supplementary Concept]
- decaprenoxanthin [MeSH Supplementary Concept]
- deepoxyneoxanthin [MeSH Supplementary Concept]
- deoxyflexixanthin [MeSH Supplementary Concept]
- diadinoxanthin [MeSH Supplementary Concept]
- diatoxanthin [MeSH Supplementary Concept]
- dipalmityl zeaxanthin [MeSH Supplementary Concept]
- fucoxanthin [MeSH Supplementary Concept]
- halocynthiaxanthin [MeSH Supplementary Concept]
- isofucoxanthin [MeSH Supplementary Concept]
- mutatoxanthin [MeSH Supplementary Concept]
- myxol dimethylfucoside [MeSH Supplementary Concept]
- neochrome [MeSH Supplementary Concept]
- neoxanthin [MeSH Supplementary Concept]
- nitrocapsanthin [MeSH Supplementary Concept]
- nitrofucoxanthin [MeSH Supplementary Concept]
- nostoxanthin [MeSH Supplementary Concept]
- rhodoxanthin [MeSH Supplementary Concept]
- sarcinaxanthin [MeSH Supplementary Concept]
- siphonaxanthin [MeSH Supplementary Concept]
- spirilloxanthin [MeSH Supplementary Concept]
- staphyloxanthin [MeSH Supplementary Concept]
- succinic acid mono-(4-(18-(4-(3-carboxypropionyloxy)-2,6,6-trimethyl-3-oxocyclohex-1-enyl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl)-3,5,5-trimethyl-2-oxocyclohex-3-enyl) ester [MeSH Supplementary Concept]
- thermozeaxanthin-15 [MeSH Supplementary Concept]
- triophaxanthin [MeSH Supplementary Concept]
- violaxanthin [MeSH Supplementary Concept]
- xancor [MeSH Supplementary Concept]
- xanthophyll plectaniaxanthin [MeSH Supplementary Concept]
- zeaxanthin 3,3'-beta-D-diglucoside [MeSH Supplementary Concept]
- zeaxanthin diglucoside [MeSH Supplementary Concept]
- zeaxanthin dipalmitate [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
Validated automatic mappings to BTNT
- lutein [Substance BNPC]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients